Influenza

Influenza management during the current severe epidemic requires a nuanced approach to testing and treatment, especially given the concurrent circulation of COVID-19 and RSV. CDC data indicates that the current season has already doubled the hospitalizations and mortality rates seen throughout the entirety of the previous year. While clinical suspicion often guides care, the presence of multiple respiratory viruses necessitates rapid PCR testing to ensure appropriate antiviral administration. High-risk groups, including the elderly, pregnant individuals, and those with chronic comorbidities, benefit significantly from early intervention, which reduces the incidence of pneumonia and hospital admissions. Although antiviral medications like oseltamivir carry risks of gastrointestinal side effects, their role in preventing severe complications remains vital. Dr. T.R. Eckler emphasizes that aligning clinical practices across urgent care and emergency departments helps standardize care and improves patient outcomes during peak viral activity.